CORRESP Filing
TriSalus Life Sciences, Inc.
Date: June 6, 2025 · CIK: 0001826667 · Accession: 0001104659-25-057451
AI Filing Summary & Sentiment
File numbers found in text: 333-287696
Show Raw Text
CORRESP 1 filename1.htm TriSalus Life Sciences, Inc. 6272 W. 91 st Ave. Westminster, Colorado 80031 June 6, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F. Street N.E. Washington, D.C. 20549-3010 Attention: Nicholas O'Leary Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 May 30, 2025 File No. 333-287696 Ladies and Gentlemen: TriSalus Life Sciences, Inc. (the " Registrant ") hereby requests that the U.S. Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Wednesday, June 11, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Dylan Kornbluth of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Dylan Kornbluth of Cooley LLP, counsel to the Registrant, at (858) 550-6173. [ Signature Page Follows ] Very truly yours, TRISALUS LIFE SCIENCES, INC. By: /s/ Mary Szela Name: Mary Szela Title: Chief Executive Officer cc: Carlos Ramirez, Cooley LLP Matthew T. Browne, Cooley LLP Dylan Kornbluth, Cooley LLP [Company Signature Page to Acceleration Request]